ENDRA LIFE SCIENCES INC. Amortization of Debt Issuance Costs and Discounts
ENDRA LIFE SCIENCES INC. (NDRA) reported Amortization of Debt Issuance Costs and Discounts of $232.43 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2021-03-25
- ENDRA LIFE SCIENCES INC. amortization of debt issuance costs and discounts for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- ENDRA LIFE SCIENCES INC. amortization of debt issuance costs and discounts for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- ENDRA LIFE SCIENCES INC. amortization of debt issuance costs and discounts for the quarter ending 2016-12-31 was $338.16K.
- ENDRA LIFE SCIENCES INC. amortization of debt issuance costs and discounts for the quarter ending 2016-09-30 was $346.12K.
- ENDRA LIFE SCIENCES INC. amortization of debt issuance costs and discounts for fiscal 2020 was $232.43K, a 90.13% decline from fiscal 2019.
- ENDRA LIFE SCIENCES INC. amortization of debt issuance costs and discounts for fiscal 2019 was $2.36M, a 223.00% increase from fiscal 2018.
- ENDRA LIFE SCIENCES INC. amortization of debt issuance costs and discounts for fiscal 2018 was $729.24K, a 2.50% increase from fiscal 2017.
- ENDRA LIFE SCIENCES INC. amortization of debt issuance costs and discounts for fiscal 2017 was $711.47K, a 20.95% decline from fiscal 2016.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2020-12-31 | $232.43K 10-K · filed 2021-03-25 | |||
| 2019-12-31 | $2.36M 10-K · filed 2021-03-25 | |||
| 2018-12-31 | $729.24K 10-K · filed 2020-03-26 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $0.00 derived: sum of 2 quarters · filed 2018-03-20 | $711.47K 10-K · filed 2018-03-20 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $711.47K 10-Q · filed 2017-11-14 | ||
| 2017-06-30 | $711.47K 10-Q · filed 2017-08-07 | |||
| 2016-12-31 | $338.16K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $684.28K derived: sum of 2 quarters · filed 2018-03-20 | $899.98K 10-K · filed 2018-03-20 | |
| 2016-09-30 | $346.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $561.81K 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $215.69K 10-Q · filed 2017-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |